KITLG and triple-negative breast carcinoma: Validation of these changes shows that the major mechanism defining acquired RH1 resistance of the triple negative breast cancer cells is linked to the alteration of the activity of multiple protein kinases including downregulation of JNK and enrichment of cancer stem cell population via autocrine stimulation of stem cell factor (SCF) and c-KIT signaling axis.